J W Alexander
Overview
Explore the profile of J W Alexander including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
553
Citations
2970
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Addressing morbid obesity as a barrier to renal transplantation with laparoscopic sleeve gastrectomy
Freeman C, Woodle E, Shi J, Alexander J, Leggett P, Shah S, et al.
Am J Transplant
. 2015 Feb;
15(5):1360-8.
PMID: 25708829
Morbid obesity is a barrier to renal transplantation and is inadequately addressed by medical therapy. We present results of a prospective evaluation of laparoscopic sleeve gastrectomy (LSG) for patients failing...
2.
Ma C, Hwang P, Alexander J
Int Nurs Rev
. 2010 May;
57(1):78-84.
PMID: 20487478
Aims: To explore the relevance and feasibility of using the Magnet Recognition Programme (MRP) at a Taiwanese hospital. Background: Since no hospitals in Taiwan have applied for American Nurses Credentialing...
3.
Duan L, Chen X, Alexander J
J Gastrointest Surg
. 2010 May;
14(7):1180-5.
PMID: 20431976
Objectives: To investigate the regulatory effect of histamine on the barrier function of intestinal mucosal. Methods: The monolayer Caco-2 cell system in vitro and the model of hemorrhage infection in...
4.
Smith S, Lindsey R, Doherty B, Alexander J, Dickson J
Eur Spine J
. 2010 Jan;
1(4):222-5.
PMID: 20054921
The AO cervical spine locking plate (CSLP) for anterior subaxial fixation was recently received increasing clinical acclaim, yet to date the in vitro mechanical properties of this implant have not...
5.
Gennari R, Alexander J, Eaves-Pyles T, Coyne T, Testori A, Geraghty J
Clin Nutr
. 2006 Jul;
16(5):247-9.
PMID: 16844603
Ribonucleic acid (RNA) has been shown to have a key role in the maintenance of normal cellular function and host resistance to infection. The effect of experimental diets containing RNA...
6.
Trofe J, Gordon J, Roy-Chaudhury P, Koralnik I, Atwood W, Eash S, et al.
Exp Clin Transplant
. 2005 Apr;
2(1):162-73.
PMID: 15859923
Over the last decade, polyomavirus nephropathy (PVN) has emerged as an important cause of renal allograft dysfunction and graft loss. PVN occurs with a prevalence of 1%-8% in renal transplant...
7.
Boardman R, Alloway R, Alexander J, Buell J, Cardi M, First M, et al.
Transplant Proc
. 2005 Apr;
37(2):814-6.
PMID: 15848541
African Americans have historically been considered high-risk renal transplant recipients due to increased rejection rates and reduced long-term graft survival. Modern immunosuppression has reduced rejections and improved graft survival in...
8.
Rogers C, Alloway R, Boardman R, Trofe J, Hanaway M, Alexander J, et al.
Transplant Proc
. 2005 Apr;
37(2):812-3.
PMID: 15848540
Unlabelled: A primary reason to eliminate corticosteroids from immunosuppressive regimens in solid organ transplant recipients is improved cardiovascular risk profiles. Although a number of studies have documented that corticosteroid withdrawal...
9.
Histocompatibility testing predicts acute rejection risk in early corticosteroid withdrawal regimens
Woodle E, Susskind B, Alloway R, Hanaway M, Thomas M, Buell J, et al.
Transplant Proc
. 2005 Apr;
37(2):809-11.
PMID: 15848539
Unlabelled: Histocompatibility testing has been shown to predict acute rejection risk in steroid-based immunosuppression. However, little evidence exists of its ability to predict acute rejection risk in corticosteroid-free patients, with...
10.
Alloway R, Trofe J, Boardman R, Rogers C, Hanaway M, Buell J, et al.
Transplant Proc
. 2005 Apr;
37(2):802-3.
PMID: 15848537
Background: The first prospective trial of steroid withdrawal dedicated to high-immunologic-risk patients is reported herein. Methods: Twenty-five patients were enrolled prospectively in an IRB-approved HIPAA-compliant protocol. Immunosuppression included corticosteroid withdrawal...